| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
6.27 |
Evidence |
|
| AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
AVPR1A |
AVPR1A, AVPR1: Vasopressin V1a receptor |
6.27 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
STK10 |
STK10: Uncharacterized protein STK10 |
6.27 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
CASKIN2 |
CASKIN2, KIAA1139: Caskin-2 |
6.27 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
ZNF551 |
IPI00157058 |
6.27 |
Evidence |
|
| JUND |
JUND: Transcription factor jun-D |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
6.27 |
Evidence |
|
| HIST1H1B |
HIST1H1B, H1F5: Histone H1.5 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
6.27 |
Evidence |
|
| RRAS |
RRAS: Ras-related protein R-Ras precursor |
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
6.27 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
6.27 |
Evidence |
|
| SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
ZNF551 |
IPI00157058 |
6.27 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
DAB2 |
DAB2, DOC2: Disabled homolog 2 |
6.27 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
6.27 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
HIST1H1B |
HIST1H1B, H1F5: Histone H1.5 |
6.27 |
Evidence |
|
| RGS18 |
RGS18, RGS13: Regulator of G-protein signaling 18 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
6.267 |
Evidence |
|
| RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
6.267 |
Evidence |
|
| CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
SIGLEC10 |
SIGLEC10, SLG2, UNQ477/PRO940: Sialic acid-binding Ig-like lectin 10 precursor |
6.267 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
6.267 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
6.267 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
SIGLEC10 |
SIGLEC10, SLG2, UNQ477/PRO940: Sialic acid-binding Ig-like lectin 10 precursor |
6.267 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
ADAM15 |
ADAM15, MDC15: ADAM 15 precursor |
6.267 |
Evidence |
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
6.267 |
Evidence |
|
| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
PTPRC |
PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ |
6.267 |
Evidence |
|
| RGS4 |
RGS4: Regulator of G-protein signaling 4 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
6.267 |
Evidence |
|
| AMPH |
AMPH, AMPH1: Amphiphysin |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
6.267 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
6.267 |
Evidence |
|